MedWatch

The Medwatch panel: Top-execs warn against quick fix

The debate about whether to give the newest, most expensive medicine to incurably ill people – even though it only has a limited effect – has resurfaced as of late. But the Danish pharma-executives of the Medwatch panel warn decision-makers about going for the quick fix.

Be careful not to think too shortsighted!

That is the message for politicians from a number of Denmark’s most prominent pharma-executives, when asked how the country should prioritize its healthcare budget.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier